Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

235P - The efficacy of radiation therapy in ovarian carcinoma: A propensity score analysis of a population-based study

Date

23 Nov 2019

Session

Poster display session

Topics

Tumour Site

Ovarian Cancer

Presenters

Jian-Guo Zhou

Citation

Annals of Oncology (2019) 30 (suppl_9): ix77-ix90. 10.1093/annonc/mdz426

Authors

J. Zhou1, S. Jin2, H. Ma1

Author affiliations

  • 1 Department Of Oncology, Zunyi Medical College Affiliated Hospital, 563000 - Zunyi City/CN
  • 2 Department Of Orthodontics, Zunyi Medical College Affiliated Stemmatological Hospital, 563000 - Zunyi City/CN

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 235P

Background

Radiation therapy (RT) is not a standard treatment for ovarian cancer (OC). However, it can be used as an adjunctive therapy to control the local recurrent disease. We aimed to investigate whether OC patients could benefit from RT.

Methods

From 2004 to 2013, the incidence, survival, treatment, and end results data from the SEER were analyzed for cases diagnosed with OC. We examined cause-specific survival (CSS) and overall survival (OS) with 95% confidence intervals (CIs) to estimate the effect of RT from multivariate Cox regression analysis. Performed propensity score matching (PSM) method was used for OC patients who received radiotherapy versus those who did not.

Results

A total of 11140 cases were enrolled for analysis. The aggregated HR of univariate survival analysis suggested that radiotherapy had unfavorable effects on overall survival (HR 1.315, 95% CI 0.994–1.739, P = 0.055) and cancer-specific survival (HR 1.732, 95% CI 1.285–2.334, P < 0.001), but there is no significant difference in multivariate analysis (OS HR 1.315, 95% CI 0.994–1.739, P = 0.055; CSS HR 1.222, 95% CI 0.905–1.651, P = 0.191). After PSM by 1:4, 655 patients were included. Both of the effect of radiotherapy in overall survival (HR 1.341, 95% CI 0.977–1.84, P = 0.070) and cancer-specific survival (HR 1.309, 95% CI 0.931–1.838, P = 0.121) were not significant ever in univariate analysis. Multivariate analysis also found the same results (OS HR 1.232, 95% CI 0.894–1.699, P = 0.202; CSS HR 1.187, 95% CI 0.841–1.674, P = 0.330). Radiotherapy seems to have a reverse effect in regionally spread patients in stage II patients (before PMS HR 3.154, 95% CI 1.709-5.821, p < 0.01; after PMS HR = 3.543, 95% CI 1.603-7.834, p < 0.01) and non-epithelial OC patients (before PMS HR 1.748, 95% CI 1.219-2.507, p = 0.002; after PMS HR = 1.5422, 95% CI 1.021-2.329, p = 0.04).

Conclusions

In OC patients, RT does not have a proven benefit on CSS and OS overall, and it is especially not suitable for early-stage patients and non-epithelial OC patients. However, further confirmation is needed from well-designed and large-scale RCTs in the future to identify its effect in certain types of epithelial OC patients after the developed techniques.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.